Study S000619

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin: Results From a Randomized Double Blinded Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04829903
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 116
Start: 2020-01-02
Primary completion: 2021-03-29
Lead sponsor: Corporacion Parc Tauli
Conditions: Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Interventions: DRUG:Dulaglutide; DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Glycemic level [24 weeks for the duration of the study]
BMI [24 weeks for the duration of the study]
Adverse effects [24 weeks for the duration of the study]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.